Cargando…
Beta-Blocker-Related Atrioventricular Conduction Disorders—A Single Tertiary Referral Center Experience
Background and Objectives: Drug-related bradyarrhythmia is a well-documented major adverse event among beta-blocker users and a potential cause for hospitalization or additional interventions. Whether beta-blocker use is associated with specific bradyarrhythmia presentations, and how this relates to...
Autores principales: | Marcu, Dragoș Traian Marius, Adam, Cristina Andreea, Dorobanțu, Dan-Mihai, Șalaru, Delia Lidia, Sascău, Radu Andy, Balasanian, Mircea Ovanez, Macovei, Liviu, Arsenescu-Georgescu, Cătălina, Stătescu, Cristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877089/ https://www.ncbi.nlm.nih.gov/pubmed/35208643 http://dx.doi.org/10.3390/medicina58020320 |
Ejemplares similares
-
Pushing the Limits of Medical Management in HCM: A Review of Current Pharmacological Therapy Options
por: Stătescu, Cristian, et al.
Publicado: (2021) -
Acute myocardial infarction and extensive systemic thrombosis in thrombotic thrombocytopenic purpura: A case report and review of literature
por: Șalaru, Delia Lidia, et al.
Publicado: (2021) -
Novel Biomarkers of Atherosclerotic Vascular Disease—Latest Insights in the Research Field
por: Adam, Cristina Andreea, et al.
Publicado: (2022) -
The Prognostic Value of Creatine Kinase-MB Dynamics after Primary Angioplasty in ST-Elevation Myocardial Infarctions
por: Popa, Delia Melania, et al.
Publicado: (2023) -
Uric Acid—An Emergent Risk Marker for Thrombosis?
por: Țăpoi, Laura, et al.
Publicado: (2021)